Combined Military Hospital Quetta/National University of Medical Sciences (NUMS) Pakistan
Objectives: To evaluate the tumor grades in different receptors (Estrogen, Progesterone and Her-2/neu) categories and age groups among women with Breast Cancer.
Study Design: An observational cross-sectional study.
Place and Duration of Study: Oncology department, Jinnah Postgraduate Medical Center, Karachi, from Jul 2017 to Dec 2018.
Methodology: Total of 450 patients were enrolled in this study using non-probability consecutive sampling technique. The Receptors Status of Estrogen, Progesterone and Her2/neu was resolved into 4 different categories as i) Triple Positive (ER+PR+HER2+), ii) Triple Negative (ER-PR-HER2-), iii) ER+PR+Her2-, iv) ER–PR-Her2+. Age-wise, patients were divided into 3 groups.
Results: The mean age of patients was 46.57 years ± 10.82. No patient was observed with Grade I tumor while 240 with Grade II and 210 with Grade-III. 164/450 patients were observed in the ER+PR+Her2- category. Out of 164, 68.3% were Grade-II and 31.7% were Grade-III (p˂0.001). In Triple-Negative category, 94 patients were observed, 31.90% were Grade-II while 68.10% were Grade-III (p<0.001). The patients, age with tumor Grade also showed statistically significant correlation (p<0.001).
Conclusion: This study sheds light on the tumor characteristics of our local population. Majority of our patients had ER+PR+Her2– phenotype/category dominantly having Grade-II tumors followed by Triple Negative typically showing Grade-III. Many of our patients were young (aged less than 36 years) having largely Grade-III tumors while older patients of age above 51 years dominantly showed Grade-II.